Keiki Nagaharu
Keiki Nagaharu is an expert in Hematology at Mie University (Japan). Keiki Nagaharu has authored 51 publications, the most recent in 2026. SLR score: 160 (community average: 125). How the SLR is computed.
LeadR Profile
Hematology
Subspecialties: Oncology - Cardiology - Immunology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2017 - 2026
Number : 51
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Chromatin Accessibility Shapes Developmental-Specific Lineage Plasticity in Hematopoiesis. PMID 42532521 — cells, bias, precursor cell lymphoblastic leukemia-lymphoma, hematopoiesis, microscopy, electron, scanning transmission, chromatin, stem cells, plastics | Blood Adv | 2026 | 0 |
| New insights into JAK2 germline variant-driven stromal cell alterations and proinflammatory bone marrow niche remodeling in myeloproliferative neoplasms. PMID 41922799 — cells, bone marrow, neoplasms, leukemia, stromal cells | Leukemia | 2026 | 0 |
| VEGF-C-mediated cardiac lymphangiogenesis promotes inflammation resolution in autoimmune acute myocarditis in mice. PMID 41843753 — cells, genes, immunization, vascular endothelial growth factor a, lymphangiogenesis, fibrosis, heart, macrophages, vascular endothelial growth factor c, cardiovascular system, myocarditis, echocardiography, therapeutics, edema | Cardiovasc Res | 2026 | 0 |
| Embryological cellular origins and hypoxia-mediated mechanisms in PIK3CA-driven refractory vascular malformations. PMID 40234712 — cells, vascular malformations, vascular endothelial growth factor a, hypoxia, therapeutics | EMBO Mol Med | 2025 | 0 |
| A rare CALR exon 9 mutation p.E379Vfs*53 in AYA generation exhibits gain-of-function nature and can induce essential thrombocythemia; a case report. PMID 40474352 — thrombocythemia, essential, thrombocytosis, calreticulin, exons, therapeutics, mutation | Hematology | 2025 | 0 |
LeadR Networks
Main global connection map